[CLSTR]
< Back to situation

[REVISION HISTORY]

Slovakia health insurer merger proceeds

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-02 06:52 UTC → 2026-08-11 14:44 UTC · added removed

In late July 2026 2026, Penta Investments-backed Dôvera signed a share-transfer agreement with Union’s shareholder, Achmea B.V., to acquire Union’s business. The transaction is to be financed entirely from Dôvera’s own funds. Following the merger of private insurers agreement, Dôvera and Union, backed by Penta Investments, moved forward. Union submitted applications for pre-notification to the European Commission and requested approval from the Health Care Surveillance Authority (ÚDZS) to acquire 100 percent of Union’s shares. The Slovak Competition Authority announced it would not formally assess the transaction, invoking a 2020 EU Court of Justice ruling that public health insurance is exempt from competition law, and therefore acted law. Consequently, the authority is acting only as a passive observer. Parliamentarians, including MEP Veronika Cifrová Ostrihoňová and MP Oskar Dvořák, wrote to have urged the European Commission urging it to examine the deal’s impact on competition and patient rights, noting the Commission’s exclusive competence. rights. The consolidation merger will leave reduce the number of Slovak health insurers from three to two, creating a market dominated by the state-run Všeobecná zdravotná poisťovňa (VšZP) and a single large private insurer, Dôvera, to compete with Dôvera. Matúš Jurových, Director General of VšZP, noted that while the state‑run Všeobecná zdravotná poisťovňa. acquisition will not fundamentally impact VšZP’s operations, it will intensify competition. Union policyholders are scheduled to be transferred automatically for automatic transfer to Dôvera on 1 January 2027 2027, unless they request a switch to VšZP by 30 September 2026. While Union’s chief executive CEO Michal Špaňár said stated services will continue unchanged. Critics remain unchanged, critics such as MP Marek Krajčí and doctors’ union head Peter Visolajský warned that Penta’s cross‑ownership, after reporting €900 million profit from Dôvera, could give the group concentration could create a “factual duopoly” and grant Penta excessive market power and called for stricter regulation. power.

Versions

  1. 2026-08-11 14:44 UTC Slovakia health insurer merger proceeds
  2. 2026-08-02 06:52 UTC Slovakia health insurer merger proceeds
  3. 2026-07-29 10:49 UTC Slovakia private health insurer merger

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.